Purchases and Sales Made in Q3 2023 in Jazz Pharmaceuticals PLC (JAZZ)
This table provides information about the institutional ownership of Jazz Pharmaceuticals PLC (JAZZ) during Q3 2023. The information is specifically focused on institutions that hold shares of Jazz Pharmaceuticals plc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-143K- 31.42% |
$17.5M - $20.8M
|
313K
$38.5M
|
|
|
Nov 14, 2023
Q3 2023
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
SELL
|
- |
-186K- 60.99% |
$22.7M - $27.1M
|
119K
$14.6M
|
|
|
Nov 14, 2023
Q3 2023
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-199K- 10.66% |
$24.3M - $28.9M
|
1.67M
$205M
|
|
|
Nov 14, 2023
Q3 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-271K- 15.97% |
$33.1M - $39.4M
|
1.43M
$175M
|
|
|
Nov 14, 2023
Q3 2023
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-316K- 98.04% |
$38.5M - $45.9M
|
6.33K
$778K
|